Epiregulin is up-regulated in pancreatic cancer and stimulates pancreatic cancer cell growth

Biochemical and Biophysical Research Communications

Volumn 273, Issue 3, 2000, Pages 1019-1024

  Zhu, Zhaowen ^a   Kleeff, Jörg ^a   Friess, Helmut ^a   Wang, Li ^a   Zimmermann, Arthur ^a   Yarden, Yosef ^b   Büchler, Markus W ^a   Korc, Murray ^c  

^a UNIVERSITY OF BERN   (Switzerland)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chronic pancreatitis; Epidermal growth factor; Epiregulin; Pancreatic ductal adenocarcinoma

Indexed keywords

EPIREGULIN; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CHRONIC PANCREATITIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; NORMAL HUMAN; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL;

EID: 0034647713     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.3033     Document Type: Article

References (28)

1. Parker S. L., Tong T., Bolden S., Wingo P. A. Cancer statistics, 1997. CA Cancer J. Clin. 47:1997;5-27.
2. Korc M., Chandrasekar B., Yamanaka Y., Friess H., Buchler M., Beger H. G. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. J. Clin. Invest. 90:1992;1352-1360.
3. Yamanaka Y., Friess H., Kobrin M. S., Buchler M., Kunz J., Beger H. G., Korc M. Overexpression of HER2/neu oncogene in human pancreatic carcinoma. Hum. Pathol. 24:1993;1127-1134.
4. Friess H., Yamanaka Y., Kobrin M. S., Do D., Buchler M. W., Korc M. Enhanced erbB-3 expression in human pancreatic cancer correlates with tumor progression. Clin. Cancer Res. 1:1995;1413-1420.
5. Graber H. U., Friess H., Kaufmann B., Willi D., Zimmermann A., Korc M., Buchler M. W. ErbB-4 mRNA expression is decreased in non-metastatic pancreatic cancer. Int. J. Cancer. 84:1999;24-27.
6. Sarles H., Bernard J. P., Johnson C. Pathogenesis and epidemiology of chronic pancreatitis. Annu. Rev. Med. 40:1989;453-468.
7. Ashizawa N., Niigaki M., Hamamoto N., Kaji T., Katsube T., Sato S., Endoh H., Hidaka K., Watanabe M., Kinoshita Y. The morphological changes of exocrine pancreas in chronic pancreatitis. Histol. Histopathol. 14:1999;539-552.
8. Korc M., Friess H., Yamanaka Y., Kobrin M. S., Buchler M., Beger H. G. Chronic pancreatitis is associated with increased concentrations of epidermal growth factor receptor, transforming growth factor alpha, and phospholipase C gamma. Gut. 35:1994;1468-1473.
9. Friess H., Yamanaka Y., Buchler M., Hammer K., Kobrin M. S., Beger H. G., Korc M. A subgroup of patients with chronic pancreatitis overexpress the c-erb B-2 protooncogene. Ann. Surg. 220:1994;183-192.
10. Friess H., Kleeff J., Buchler M. W. Growth factors and growth factor receptors in chronic pancreatitis. Dervenis C. G. Advances in Pancreatic Disease. 1996;26-33 Georg Thieme Verlag, Stuttgart, New York.
11. Wagner M., Luhrs H., Kloppel G., Adler G., Schmid R. M. Malignant transformation of duct-like cells originating from acini in transforming growth factor transgenic mice. Gastroenterology. 115:1998;1254-1262.
12. Toyoda H., Komurasaki T., Uchida D., Takayama Y., Isobe T., Okuyama T., Hanada K. Epiregulin: A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. J. Biol. Chem. 270:1995;7495-7500.
13. Komurasaki T., Toyoda H., Uchida D., Morimoto S. Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4. Oncogene. 15:1997;2841-2848.
14. Shelly M., Pinkas-Kramarski R., Guarino B. C., Waterman H., Wang L. M., Lyass L., Alimandi M., Kuo A., Bacus S. S., Pierce J. H., Andrews G. C., Yarden Y. Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes. J. Biol. Chem. 273:1998;10496-10505.
15. Toyoda H., Komurasaki T., Uchida D., Morimoto S. Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor family. Biochem. J. 326:1997;69-75.
16. Guo X., Friess H., Graber H. U., Kashiwagi M., Zimmermann A., Korc M., Buchler M. W. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. Cancer Res. 56:1996;4876-4880.
17. Korc M., Matrisian M. L., Planck S. R., Magun B. M. Binding of epidermal growth factor in rat pancreatic acini. Biochem. Biophys. Res. Commun. 111:1983;1066-1073.
18. Brannon P. M., Hirschi K., Korc M. Effects of epidermal growth factor, insulin, and insulin-like growth factor on rat pancreatic acinar cells cultured in serum-free medium. Pancreas. 3:1988;41-48.
19. Logsdon C. D. Stimulation of pancreatic acinar cell growth by CCK, EGF and insulin in vitro. Am. J. Physiol. 251:1986;G487-G494.
20. Pipper A., Stryjek-Kaminska D., Zeuzem S. Epidermal growth factor activates phospholipase C-gamma 1 via G(i) 1-2 proteins in isolated pancreatic acinar membranes. Am. J. Physiol. 272:1997;1276-1284.
21. Vinter-Jensen L., Juhl C. O., Teglbjaerg P S., Poulsen S. S., Dajani E. Z., Nexo E. Systemic treatment with EGF in pigs induces ductal proliferations in the pancreas. Gastroenterology. 113:1997;1367-1374.
22. Shirakata Y., Komurasaki T., Toyoda H., Hanakawa Y., Yamasaki K., Tokumaru S., Sayama K., Hashimoto K. Epiregulin, a novel member of the epidermal growth factor family, is an autocrine growth factor in normal human keratinocytes. J. Biol. Chem. 2000;275-253.
23. Yokoyama Y., Funatomi H., Kobrin M. S., Ebert M., Friess H., Buchler M. W., Korc M. Betacellulin, a member of the EGF family is overexpressed in human pancreatic cancer. Int. J. Oncol. 7:1995;825-829.
24. Kobrin M. S., Funatomi H., Friess H., Buchler M. W., Stathias P., Korc M. Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer. Biochem. Biophys. Res. Commun. 202:1994;1705-1709.
25. Ebert M., Yokoyama M., Kobrin M. S., Friess H., Lopez M. E., Buchler M. W., Johnson G. R., Korc M. Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res. 54:1994;3959-3962.
26. Yokoyama M., Ebert M., Funatomi H., Friess H., Buchler M. W., Johnson G. R., Korc M. Amphiregulin is a potent mitogen in human pancreatic cancer cells: Correlation with patient survival. Int. J. Oncol. 6:1995;625-631.
27. Yamanaka Y., Friess H., Kobrin M. S., Buchler M. W., Beger H. G., Korc M. Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness. Anticancer Res. 13:1993;565-569.
28. Smith J. J., Derynck R., Korc M. Production of transforming growth factor alpha in human pancreatic cancer cells: Evidence for a superagonist autocrine cycle. Proc. Natl. Acad. Sci. USA. 84:1987;7567-7570.